Revolutionizing Natural Male Enhancementwith AI-Nanotechnology
Blue Eyes Biotech CO., Ltd. unveils agroundbreaking delivery system that finally solves the bioavailabilitychallenge for plant-based sildenafil alternatives. Our NanoSmart™ AI platformhas engineered:
• 22nmphytosome carriers specifically for icariin/epimedium compounds
•pH-responsive release targeting duodenum absorption zones
• 3.5X greaterCmax than standard extracts (confirmed in pharmacokinetic study)
Key Advantages:
→ Bypassesfirst-pass metabolism - 68% more active compounds reach circulation
→Tasteless/maskable - ideal for functional foods and beverages
→ 12-monthstability at room temperature
Clinical Performance:
✔ Onset in 35 minutes (vs. 60+ mins forconventional extracts)
✔ 6-hour effective window confirmed byRigiscan testing
✔ Zero reported headaches (common withsynthetic PDE5 inhibitors)
"Our machine learning model analyzed50,000 gut permeability profiles to design these carriers," explains Dr.James Koh, Director of Nanotechnology.
For Product Developers:
• Ready-to-useNanoICAR™ Complex (50mg icariin equivalents/dose)
• Multipledelivery formats:
-Sublingual strips
-Effervescent tablets
-Gummy formulations
• Fulldocumentation:
-3D molecular modeling reports
-28-day human trial data
-Non-GMO/vegan certifications
Get the Technical Dossier:
Email: [email protected]
Visit: www.blueeyes-bio.com